SEC 13F Intelligence

Samson Rock Capital LLP / ALXN

Samson Rock Capital LLP’s Alexion Pharmaceuticals Inc Position

Does Samson Rock Capital LLP own Alexion Pharmaceuticals Inc (ALXN)? Not currently — the last reported position was 382.6K shares worth $70M in Q2 2021; the fund’s latest 13F (Q2 2026) no longer reports it.

Position Value
$70M
Q2 2021
Shares
382.6K
% of Portfolio
+13.85%
Quarters Held
2
position exited

Position History ALXN

Reported value by quarter
Q1 ’21: $15MQ1 ’21Q2 ’21: $70MQ2 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2021382.6K$70M+13.85%
Q1 2021100.0K$15M+3.82%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Samson Rock Capital LLP’s full portfolio or all institutional holders of ALXN.